Edition:
United Kingdom

Brainstorm Cell Therapuetics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.36USD
18 Apr 2018
Change (% chg)

$-0.04 (-1.18%)
Prev Close
$3.40
Open
$3.36
Day's High
$3.36
Day's Low
$3.36
Volume
1,036
Avg. Vol
15,156
52-wk High
$5.15
52-wk Low
$2.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 0.015
Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
FY 2016 Dec '16 0.00 -0.033
Sep '16 0.00 -0.086
Jun '16 0.00 -0.052
Mar '16 0.00 -0.096
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 1 -0.28 -0.28 -0.28 -0.25
Quarter Ending Sep-18 1 -0.27 -0.27 -0.27 -0.24
Year Ending Dec-18 1 -1.17 -1.17 -1.17 -1.05
Year Ending Dec-19 1 -1.20 -1.20 -1.20 -1.08
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.05 32.74
P/E High - Last 5 Yrs. -- 293.18 45.72
P/E Low - Last 5 Yrs. -- 91.59 24.22
Beta 1.54 0.90 0.88
Price to Sales (TTM) -- 110.91 5.71
Price to Book (MRQ) 10.34 13.58 5.37
Price to Tangible Book (MRQ) 10.39 14.04 6.95
Price to Cash Flow (TTM) -- 71.43 23.32
% Owned Institutions 12.71 12.76 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 399.23 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 78.85 5.69
Sales - 5 Yr. Growth Rate -- 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -7.62 25.02 19.36
EPS (TTM) vs TTM 1 Yr. Ago 25.48 -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.76
Capital Spending - 5 Yr. Growth Rate 16.50 40.30 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) 10.80 5.30 2.98
LT Debt to Equity (MRQ) 0.00 22.97 12.18
Total Debt to Equity (MRQ) 0.00 24.63 16.45
Interest Coverage (TTM) -- -99.38 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.44
Gross Margin - 5 Yr. Avg. -- 51.15 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -574.95 10.96
Operating Margin (TTM) -- -718.73 4.73
Operating Margin - 5 Yr. Avg. -- -596.27 6.40
Pre-Tax Margin (TTM) -- -693.19 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.63 6.81
Net Profit Margin (TTM) -- -694.42 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.48 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,634,794 846,834,920
Net Income/Employee (TTM) -- 2,972,499 99,616,660
Receivable Turnover (TTM) -- 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.79 -1.10 10.95
Return on Assets - 5 Yr. Avg. -71.19 -0.57 12.31
Return on Investment (TTM) -52.76 1.59 14.38
Return on Investment - 5 Yr. Avg. -91.15 2.21 16.10
Return on Equity (TTM) -52.76 2.42 16.07
Return on Equity - 5 Yr. Avg. -93.46 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 42.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapuetics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.60%
# of Holders: 42
Total Shares Held: 1,830,986
3 Mo. Net Change: 1,813
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 0
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.